RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Aida Pharmaceuticals Stock

Aida Pharmaceuticals Equity 2024

Aida Pharmaceuticals Equity

0 USD

Ticker

AIDA

ISIN

US0087211027

WKN

A0YHEN

In 2024, Aida Pharmaceuticals's equity was 0 USD, a 0% increase from the 0 USD equity in the previous year.

Aida Pharmaceuticals Aktienanalyse

What does Aida Pharmaceuticals do?

Aida Pharmaceuticals Inc is a US-based company that manufactures and distributes pharmaceuticals, dietary supplements, and cosmetic products. The company was founded in 2005 by Dr. Wei Li and is headquartered in Fremont, California. Aida Pharmaceuticals Inc aims to provide a comprehensive alternative for the healthcare industry. It has become a key player in the international market and has expanded its presence on different continents. The company's business model focuses on manufacturing and marketing high-quality products. Aida Pharmaceuticals Inc combines traditional and modern medicine to offer alternative and effective healthcare solutions. The company is divided into three divisions: Pharmaceuticals, offering a variety of prescription drugs tailored to patient needs; Dietary Supplements, providing natural supplements for various health areas; and Cosmetics, offering a wide range of beauty products based on natural ingredients. Aida Pharmaceuticals Inc is known for its quality and effective products, maintaining strict quality standards and selecting the right ingredients. Some of its notable products include Metoprolol for hypertension and heart diseases, Vitamin D3 for bone strength, and Retinol Serum for reducing wrinkles and improving skin structure. Overall, Aida Pharmaceuticals Inc specializes in manufacturing and marketing pharmaceuticals, dietary supplements, and cosmetic products, catering to the diverse health and beauty needs of its customers. The company prioritizes quality and effectiveness and has established itself as a key player in the international market. Aida Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Aida Pharmaceuticals's Equity

Aida Pharmaceuticals's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Aida Pharmaceuticals's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Aida Pharmaceuticals's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Aida Pharmaceuticals's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Aida Pharmaceuticals’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Aida Pharmaceuticals stock

What is the equity of Aida Pharmaceuticals this year?

Aida Pharmaceuticals has equity of 0 USD this year.

What was the equity of Aida Pharmaceuticals compared to the previous year?

The equity of Aida Pharmaceuticals has increased/decreased by 0% decreased compared to the previous year.

What impact does a high equity have on investors of Aida Pharmaceuticals?

A high equity is advantageous for investors of Aida Pharmaceuticals as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Aida Pharmaceuticals?

A low equity can be a risk for investors of Aida Pharmaceuticals, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Aida Pharmaceuticals affect the company?

An increase in equity of Aida Pharmaceuticals can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Aida Pharmaceuticals affect the company?

A reduction in equity of Aida Pharmaceuticals can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Aida Pharmaceuticals?

Some factors that can affect the equity of Aida Pharmaceuticals include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Aida Pharmaceuticals so important for investors?

The equity of Aida Pharmaceuticals is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Aida Pharmaceuticals take to change the equity?

To change equity, Aida Pharmaceuticals can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Aida Pharmaceuticals pay?

Over the past 12 months, Aida Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aida Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Aida Pharmaceuticals?

The current dividend yield of Aida Pharmaceuticals is .

When does Aida Pharmaceuticals pay dividends?

Aida Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Aida Pharmaceuticals?

Aida Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Aida Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aida Pharmaceuticals located?

Aida Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Aida Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aida Pharmaceuticals from 12/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/30/2024.

When did Aida Pharmaceuticals pay the last dividend?

The last dividend was paid out on 12/30/2024.

What was the dividend of Aida Pharmaceuticals in the year 2023?

In the year 2023, Aida Pharmaceuticals distributed 0 USD as dividends.

In which currency does Aida Pharmaceuticals pay out the dividend?

The dividends of Aida Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Aida Pharmaceuticals

Our stock analysis for Aida Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aida Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.